Log In Get Started

Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,605 total articles

MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media
Sep 29, 2026
Marcus Reed
Press Releases

MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media

MindWave Innovations Inc., a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), has entered a 12-month agreement with Flash Sports & Media Holdings, Inc. (OTC: FLZH) to build and operate FlashChain, a blockchain dedicated to managing digital sports broadcasting rights, media assets, and ticketing inventory. MindWave …

APUS
Host Digital Letter to Shareholders
Sep 29, 2026
Derek Hwang
Press Releases

Host Digital Letter to Shareholders

Host Digital Inc. CEO Harmol Samra addresses shareholders detailing the company's transition to a public entity and its focus on developing, owning, and operating RightScaled data centers (20 to 100 megawatts) with existing or near-term access to power tailored for AI and high-performance computing workloads. The letter highlights the signed 15-yea…

HOST
Trident Digital Tech Holdings (Nasdaq: TDTH) Completes US$15 Million Equity Offering, Bringing September Financing to Approximately US$23 Million to Fund Execution of Its AI and Digital Infrastructure Strategy
Sep 29, 2026
Hana Yamamoto
Press Releases

Trident Digital Tech Holdings (Nasdaq: TDTH) Completes US$15 Million Equity Offering, Bringing September Financing to Approximately US$23 Million to Fund Execution of Its AI and Digital Infrastructure Strategy

Trident Digital Tech Holdings Ltd successfully completed an equity offering totaling approximately $23 million in September 2026 to fund its AI and digital infrastructure strategy. The entirely equity-based financing strengthens Trident's balance sheet without adding debt, following compliance restoration with Nasdaq listing requirements. The compa…

TDTH
J-Star Holding Co., Ltd. Chairman and CEO Jonathan Chiang to Relocate to the United States to Lead Growth Initiatives
Sep 29, 2026
Priya Menon
Press Releases

J-Star Holding Co., Ltd. Chairman and CEO Jonathan Chiang to Relocate to the United States to Lead Growth Initiatives

J-Star Holding Co., Ltd., a Nasdaq-listed manufacturer of carbon fiber and composite materials, announced that its Chairman and CEO Jonathan Chiang will relocate full-time to the United States. This move aims to strengthen the company's U.S. presence and accelerate growth by focusing on higher-value applications in healthcare, automotive, aerospace…

YMAT
Alpha Compute Operating Oil and Gas Assets Due Diligence Estimates 2.9 million barrels of Oil Reserves and $100 million in Natural Gas reserves that can power 200MW for Data Center
Sep 29, 2026
Derek Hwang
Press Releases

Alpha Compute Operating Oil and Gas Assets Due Diligence Estimates 2.9 million barrels of Oil Reserves and $100 million in Natural Gas reserves that can power 200MW for Data Center

Alpha Compute Corp. announced progress on its purchase of oil, gas, and mineral assets in Pennsylvania, estimating 2.9 million barrels of oil in place and significant natural gas reserves capable of powering up to 200 MW for its planned Q1 2028 data center. The acquisition includes more than 75 active oil wells, infrastructure, and surface rights a…

ALP
Hawkins, Inc. Expands into Texas’ Dallas–Fort Worth Region with Acquisition of Eagle Labs, Inc.
Sep 29, 2026
Ajmal Hussain
Press Releases

Hawkins, Inc. Expands into Texas’ Dallas–Fort Worth Region with Acquisition of Eagle Labs, Inc.

Hawkins, Inc. completed the acquisition of Eagle Labs, Inc., enhancing its water treatment distribution and manufacturing capabilities in the Dallas–Fort Worth region. This strategic move extends Hawkins' footprint in Texas to seven water treatment facilities, positioning the company in one of the fastest-growing U.S. metropolitan markets and stren…

HWKN
Telitacicept Demonstrates Deep and Durable Minimal Symptom  Expression Through 48 Weeks in Generalized Myasthenia Gravis
Sep 29, 2026
Leila Farooq
Press Releases

Telitacicept Demonstrates Deep and Durable Minimal Symptom  Expression Through 48 Weeks in Generalized Myasthenia Gravis

Vor Bio announced positive results from a 48-week post hoc analysis of its Phase 3 trial of telitacicept in generalized myasthenia gravis (gMG). The study demonstrated that telitacicept provides deep and durable symptom relief, with 42% of treated participants achieving minimal symptom expression (MSE) and sustained improvements maintained over the…

VOR
Tessera Sets 2027 Revenue Target of $14–16 Million and Outlines Path to Approximately $30 Million by 2029
Sep 29, 2026
Jordan Park
Press Releases

Tessera Sets 2027 Revenue Target of $14–16 Million and Outlines Path to Approximately $30 Million by 2029

Tessera Defense and Homeland Security Inc. announced an ambitious financial outlook with a 2027 revenue target of $14-$16 million and a goal of approximately $30 million by 2029, fueled by expansion of its integrated physical security platform across new and existing customers, markets, and acquisitions. The strategy focuses on increasing platform …

HLSQ
Silexion Therapeutics Announces Exercise of Warrants
Sep 29, 2026
Hana Yamamoto
Press Releases

Silexion Therapeutics Announces Exercise of Warrants

Silexion Therapeutics Corp., a clinical-stage biotech focused on RNAi therapies for KRAS-driven cancers, announced the immediate exercise of outstanding series E warrants to purchase over 3.2 million shares at a reduced price of $0.2603 per share, raising approximately $837,000 before expenses. The company issued new unregistered Series F and G war…

SLXN
Asure Launches AsureCentral to Its Reseller Network, Extending Its Unified Platform to 85,000 More Employers
Sep 29, 2026
Leila Farooq
Press Releases

Asure Launches AsureCentral to Its Reseller Network, Extending Its Unified Platform to 85,000 More Employers

Asure Software has launched its AsureCentral platform to its reseller network, extending access from 30,000 direct employer clients to over 85,000 additional employer clients served by resellers. This integration enables resellers to manage payroll, HR, recruiting, time and attendance, and benefits solutions in a single platform, improving user exp…

ASUR
Byrna Technologies Launches Media Campaign with iHeartMedia’s “The Bobby Bones Show” to Expand Mainstream Reach
Sep 29, 2026
Maya Rios
Press Releases

Byrna Technologies Launches Media Campaign with iHeartMedia’s “The Bobby Bones Show” to Expand Mainstream Reach

Byrna Technologies Inc., a Nasdaq-listed personal defense company, has partnered with iHeartMedia's popular The Bobby Bones Show to launch a national media campaign. The campaign includes radio endorsements, podcasts, and digital placements aimed at expanding brand awareness and educating consumers on Byrna’s less-lethal personal safety devices. Th…

BYRN
ZenaTech Reports 425% First Half and 316% Second-Quarter Year-Over-Year Revenue Growth as Drone as a Service Segment Continues to Scale
Sep 29, 2026
Hana Yamamoto
Press Releases

ZenaTech Reports 425% First Half and 316% Second-Quarter Year-Over-Year Revenue Growth as Drone as a Service Segment Continues to Scale

ZenaTech, Inc. reported a remarkable 316% year-over-year revenue increase in Q2 2026 and a 425% increase in the first half of 2026, primarily fueled by its Drone as a Service (DaaS) segment. The company expanded its geographic footprint through multiple acquisitions and newly opened offices internationally. Investments in AI-powered drone technolog…

ZENA
Phase III Trial Demonstrates Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation
Sep 29, 2026
Caleb Monroe
Press Releases

Phase III Trial Demonstrates Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation

Veracyte announced that a retrospective analysis of the phase III NRG/RTOG 0815 trial demonstrates their Decipher Prostate Genomic Classifier can predict which intermediate-risk prostate cancer patients benefit from adding short-term androgen deprivation therapy (ADT) to radiation. Patients with higher Decipher scores saw a significant reduction in…

VCYT
Brunswick Corporation Announces Senior Leadership Appointments
Sep 29, 2026
Nina Shah
Press Releases

Brunswick Corporation Announces Senior Leadership Appointments

Brunswick Corporation has announced the appointment of Will Sangster as EVP and President of Navico Group, Karly Yuds as SVP and President of Business Acceleration, and Marco Bracalente as Chief Technology Officer. These senior leadership changes follow the recent CEO and Board Chair transitions effective January 1, 2027. The appointments reflect B…

BC
Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)
Sep 29, 2026
Derek Hwang
Press Releases

Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)

Tectonic Therapeutic announced favorable safety, tolerability, and pharmacokinetic results from its Phase 1a clinical trial of TX2100, a novel APJ receptor antagonist antibody for treating Hereditary Hemorrhagic Telangiectasia (HHT). The FDA granted Fast Track designation for TX2100 and cleared the IND application for a Phase 1b trial in HHT patien…

TECX
Corbus Pharmaceuticals Announces First Patient Dosed in TEMPO-1 Registrational Study of CRB-701 in Patients with 2L+ Oropharyngeal Cancer
Sep 29, 2026
Derek Hwang
Press Releases

Corbus Pharmaceuticals Announces First Patient Dosed in TEMPO-1 Registrational Study of CRB-701 in Patients with 2L+ Oropharyngeal Cancer

Corbus Pharmaceuticals has dosed the first patient in its TEMPO-1 registrational study evaluating CRB-701, a novel Nectin-4 targeted antibody drug conjugate, for treatment of second-line and beyond oropharyngeal squamous cell carcinoma (OPSCC). The Phase 3 randomized controlled trial aims to confirm the drug's efficacy and safety compared to curren…

CRBP